LNSR

4.4603.88%
GM

Gary M. Winer

Independent Director

Mr. Gary M. Winer is the Co-Founder and Director at SmartHealth Catalyzer Inc. He was Independent Director at HCW Biologics Inc. since October 27, 2021 until June 17, 2025. He serves as Director at Bionode LLC. He is Member of Advisory Board at Schedule 1 Therapeutics, Inc. He has been Independent Director at LENSAR, Inc. since April 2018. Mr. Winer served as President, Chief Executive Officer and Director at ORGENTEC Diagnostika GmbH since April 9, 2019 until September 2021. Since January 2015, Mr. Winer also works as a consultant for DRC Health Care Advisors since 2015, which consults with companies in the biopharma, medical device and diagnostic health sectors. From 2003 to 2014, Mr. Winer served as divisional Vice President for Abbott Laboratories, or Abbott, divisional Vice President for Abbott’s U.S. Commercial Operations and for Canadian diagnostic business unit and corporate Vice President and President for Abbott Japan. Mr. Winer served as AbbVie Japan’s executive President and Chief Executive Officer from January 2013 to March 2014. He served as Vice President of Global Commercial Strategies at AbbVie from April 2014 to January 2015. Mr. Winer also serves on the Board of Directors for several private healthcare companies. Mr. Winer holds a B.S. in Finance from California State University and an M.B.A. from Northwest University’s Kellogg Graduate School.

Positions